ADRB2 and diabetes mellitus: Our work may have suggested HSL inhibitors could be a viable alternative to β-AR antagonists as a safer therapeutics for CRC patients who are under psychological stress or have to intake diet with a relatively high-fat content due to other complications such as diabetes mellitus.